1. 308 Tralokinumab provides other clinically meaningful improvements in adolescents with moderate-to-severe atopic dermatitis who did not achieve IGA 0/1 at week 16. (25th January 2023) Authors: Paller, Amy; Blauvelt, Andrew; Soong, Weily; Hong, Chih-ho; Schuttelaar, Marie L A; Schneider, Shannon ; Moerch, Marie Holst; Simpson, Eric Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma. Issue 1 (December 2016) Authors: Harris, Jeffrey; Maciuca, Romeo; Bradley, Mary; Cabanski, Christopher; Scheerens, Heleen; Lim, Jeremy; Cai, Fang; Kishnani, Mona; Liao, X.; Samineni, Divya; Zhu, Rui; Cochran, Colette; Soong, Weily; Diaz, Joseph; Perin, Patrick; Tsukayama, Miguel; Dimov, Dimo; Agache, Ioana; Kelsen, Steven Journal: Respiratory research Issue: Volume 17:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Differing perceptions of asthma control and treatment effectiveness by patients with severe asthma and treating subspecialists in the United States. (2nd September 2022) Authors: Panettieri, Reynold A.; Chipps, Bradley E.; Moore, Wendy C.; Soong, Weily; Carr, Warner W.; Kreindler, James L.; O'Quinn, Sean; Trudo, Frank; Ambrose, Christopher S. Journal: Journal of asthma Issue: Volume 59:Number 9(2022) Page Start: 1859 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10356 (17th September 2022) Authors: Paller, Amy S; Simpson, Eric L; Siegfried, Elaine C; Cork, Michael J; Wollenberg, Andreas; Arkwright, Peter D; Soong, Weily; Gonzalez, Mercedes E; Schneider, Lynda C; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; ... Journal: Lancet Issue: Volume 400:Issue 10356(2022) Page Start: 908 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial. Issue 10348 (23rd July 2022) Authors: Reich, Kristian; Thyssen, Jacob P; Blauvelt, Andrew; Eyerich, Kilian; Soong, Weily; Rice, Zakiya P; Hong, H Chih-ho; Katoh, Norito; Valenzuela, Fernando; DiBonaventura, Marco; Bratt, Tamara A; Zhang, Fan; Clibborn, Claire; Rojo, Ricardo; Valdez, Hernan; Kerkmann, Urs Journal: Lancet Issue: Volume 400:Issue 10348(2022) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Issue 10013 (2nd January 2016) Authors: Thaçi, Diamant; Simpson, Eric L; Beck, Lisa A; Bieber, Thomas; Blauvelt, Andrew; Papp, Kim; Soong, Weily; Worm, Margitta; Szepietowski, Jacek C; Sofen, Howard; Kawashima, Makoto; Wu, Richard; Weinstein, Steven P; Graham, Neil M H; Pirozzi, Gianluca; Teper, Ariel; Sutherland, E Rand; Mastey, Vera;... Journal: Lancet Issue: Volume 387:Issue 10013(2016) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD. (July 2016) Authors: Donohue, James F.; Soong, Weily; Wu, Xiao; Shrestha, Pomy; Lei, Alejhandra Journal: Respiratory medicine Issue: Volume 116(2016) Page Start: 41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10 (October 2021) Authors: Han, Joseph K; Bachert, Claus; Fokkens, Wytske; Desrosiers, Martin; Wagenmann, Martin; Lee, Stella E; Smith, Steven G; Martin, Neil; Mayer, Bhabita; Yancey, Steven W; Sousa, Ana R; Chan, Robert; Hopkins, Claire; Ahlström Emanuelsson, Cecilia; Ardusso, Ledit; Armstrong, Michael; Bardin, Philip; Ba... Journal: Lancet Issue: Volume 9:Issue 10(2021) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial. Issue 3 (March 2021) Authors: Harrison, Tim W; Chanez, Pascal; Menzella, Francesco; Canonica, Giorgio Walter; Louis, Renaud; Cosio, Borja G; Lugogo, Njira L; Mohan, Arjun; Burden, Annie; McDermott, Lawrence; Garcia Gil, Esther; Zangrilli, James G; Pohl, Wolfgang; Voves, Robert; Deschampheleire, Maud; Louis, Renaud; Martinot, ... Journal: Lancet Issue: Volume 9:Issue 3(2021) Page Start: 260 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10290 (5th June 2021) Authors: Reich, Kristian; Teixeira, Henrique D; de Bruin-Weller, Marjolein; Bieber, Thomas; Soong, Weily; Kabashima, Kenji; Werfel, Thomas; Zeng, Jiewei; Huang, Xiaohong; Hu, Xiaofei; Hendrickson, Barbara A; Ladizinski, Barry; Chu, Alvina D; Silverberg, Jonathan I Journal: Lancet Issue: Volume 397:Issue 10290(2021) Page Start: 2169 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗